Alexandria Real Estate Equities, Inc.

This profile gathers the share dealings of Alexandria Real Estate Equities, Inc. across 2 companies, led by Applied Therapeutics Inc. and GreenLight Biosciences Holdings, PBC. The record holds 8 filings, for trades running from 23 February 2022 to 4 June 2024.

Market trades split into 1 purchase (€1.4M) and 3 sales (€1.2M). Taken together, the purchases exceed the sales by €197k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2024: no purchases and 1 sale on the market.

On 6 June 2024 came the latest disclosure, an open-market sale for €580k in Applied Therapeutics Inc. The latest purchase dates back some time: it was published 1,572 days ago, on 29 June 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.